UnknownNot Applicable

Hemostasis Assesment After Application of Lyophilisate Collagen in Nail Surgery

98 participantsStarted 2021-12-20

Plain-language summary

The objective of this study is to evaluate the hemostatic capacity of two types of collagen hemostatic sponges in nail surgery. It is a randomized triple-blind clinical trial with two experimental groups (medium porosity collagen and high porosity collagen) and control group ( non collagen).

Who can participate

Age range15 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * STADIUM I, II, or III (Kline classification) without infective onychocryptosis (cellulitis) on both edges of the Hallux * Susceptible to phenol-alcohol technique with Suppan I modification Exclusion Criteria: * Platelet Antiplatelet Therapy * Oral Anticoagulant Therapy * History of congenital or acquired Hemorrhagic Syndrome * Alteration in the following parameters (platelet count, prothrombin time, activated thromboplastin time, and plasma fibrinogen)

What they're measuring

Bleeding

Timeframe: 72 hours after surgery

Trial details

NCT IDNCT05140161

SponsorUniversity of Seville

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-29

Contact for this trial

ANTONIO CÓRDOBA FERNÁNDEZ, PHD

+34 685860512 acordoba@us.es

View on ClinicalTrials.gov More Nails, Ingrown trials